Study guide

2.4 Neonatal & Special Population Assessment: Finnegan, Eat-Sleep-Console & Life Stages

Certified Addictions Registered Nurse CARN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 CARN Exam Overview, Eligibility & Requirements 1.2 How to Use This Study Guide & Preparation Strategy

2 Chapter 2: Assessment & Screening

2.1 DSM-5-TR Substance Use Disorder Diagnostic Criteria & Severity Classification 2.2 Standardized Screening Tools: AUDIT, DAST-10, CAGE, CRAFFT & ASSIST 2.3 Withdrawal Severity Rating Scales: CIWA-Ar & COWS 2.4 Neonatal & Special Population Assessment: Finnegan, Eat-Sleep-Console & Life Stages 2.5 Assessment of Co-Occurring Psychiatric & Medical Disorders

3 Chapter 3: Planning & Intervention

3.1 ASAM Criteria & Continuum of Placement Care 3.2 Motivational Interviewing (OARS) & Transtheoretical Stages of Change 3.3 Trauma-Informed Care Principles & Addictions Nursing Practice 3.4 Family Dynamics, Codependency, CRAFT Model & Family Support Systems 3.5 Nursing Diagnosis, Outcome Identification & Individualized Addictions Care Planning

4 Chapter 4: Clinical Management & Pharmacotherapy

4.1 Alcohol Withdrawal Syndrome Management & Complication Prevention 4.2 Opioid Withdrawal Management & Symptom-Triggered Protocols 4.3 Medications for Opioid Use Disorder (MOUD: Methadone, Buprenorphine & Extended-Release Naltrexone) 4.4 Pharmacotherapy for Alcohol & Nicotine Use Disorders 4.5 Harm Reduction Strategies: Naloxone, Fentanyl Test Strips & Syringe Services 4.6 Pain Management in Patients with Substance Use Disorders

5 Chapter 5: Substance-Specific Disorders, Prevention & Patient Education

5.1 Stimulant Use Disorders: Cocaine, Amphetamines & Caffeine 5.2 Sedative, Hypnotic, Anxiolytic & Gabapentinoid Misuse 5.3 Cannabis & Hallucinogen Use Disorders 5.4 Tobacco Use Disorder, Vaping & Cessation Interventions 5.5 Prevention, Brief Intervention, Patient Education & Behavioral Addictions

6 Chapter 6: Evaluation, Recovery & Continuing Care

6.1 Relapse Prevention Models: Marlatt's Model, Urge Surfing & High-Risk Situations 6.2 Mutual-Help Groups & Peer Recovery Support: 12-Step, SMART Recovery & Peer Specialists 6.3 Recovery Capital, Social Determinants of Health & Holistic Wellness 6.4 Transitions of Care, Discharge Planning & Long-Term Recovery Management

7 Chapter 7: Professional Role, Ethics & Legal Issues

7.1 ANA/IntNSA Scope & Standards of Addictions Nursing Practice 7.2 Confidentiality Laws: 42 CFR Part 2 vs. HIPAA & 2024 Alignment Updates 7.3 Legal & Ethical Issues, Stigma Reduction & Person-First Language

2.4 Neonatal & Special Population Assessment: Finnegan, Eat-Sleep-Console & Life Stages

Key Takeaways Explain This Topic AI

The Modified Finnegan Neonatal Abstinence Scoring System (FNASS) evaluates 21 items; pharmacotherapy is traditionally indicated for scores ≥8 on two consecutive scoring periods or ≥12 on a single scoring period.

Eat, Sleep, Console (ESC) is an evidence-based, function-prioritizing care model that significantly reduces pharmacological treatment rates and NICU length of stay by prioritizing non-pharmacological caregiver interventions.

Geriatric SUD assessment must account for age-related pharmacokinetic changes (decreased renal clearance, hepatic metabolism, and total body water) which magnify toxicity at lower consumption volumes.

Perinatal substance use screening requires trauma-informed care and validated tools (e.g., SURP-P, 4Ps Plus) to overcome stigma and facilitate early multidisciplinary prenatal engagement.

Adolescent addiction evaluation requires strict observance of state privacy laws, developmental vulnerability assessment (immature prefrontal cortex), and peer/family environmental screening.

Last updated: August 2026

  • Neonatal & Special Population Assessment: Finnegan, Eat-Sleep-Console & Life Stages
  • Neonatal Opioid Withdrawal Syndrome (NOWS) Assessment

Neonatal Opioid Withdrawal Syndrome (NOWS) —historically termed Neonatal Abstinence Syndrome (NAS)—occurs in newborns exposed to opioids in utero following abrupt discontinuation of maternal transplacental passage at birth. NOWS manifests as multi-system dysfunction primarily affecting the central nervous system (CNS), gastrointestinal (GI) tract, and respiratory system.

Nurses caring for neonates at risk for NOWS must perform serial, standardized assessments to monitor withdrawal trajectory and determine when non-pharmacological interventions or morphine/methadone pharmacotherapy are required.

The Modified Finnegan Neonatal Abstinence Scoring System (FNASS)

The Modified Finnegan (FNASS) has long served as the traditional high-density scoring tool for NOWS. It evaluates 21 physical signs scored every 3 to 4 hours post-feed.

FNASS Symptom Domain Categorization

  • Functional Domain Specific Evaluated Signs Point Values
  • Central Nervous System Excessive crying / High-pitched cry 2 – 3
  • Sleep duration after feed (<1h, <2h, <3h) 1 – 3
  • Hyperactive Moro reflex / Tremors (unstimulated vs stimulated) 1 – 4
  • Increased muscle tone (hypertonia) / Myoclonic jerks 1 – 3
  • Excoriation (chin, knees, elbows) / Convulsions 1 – 8
  • Metabolic / Respiratory Sweating / Fever (>38.4°C) / Frequent yawning (>3-4 times) 1 – 2
  • Mottling / Nasal stuffiness / Sneezing (>3-4 times) 1 – 2
  • Tachypnea (>60 breaths/min) with or without retractions 1 – 2
  • Gastrointestinal Excessive sucking / Poor feeding / Uncoordinated swallow 1 – 3
  • Regurgitation / Projectile vomiting 2 – 3
  • Loose stools / Watery stools 2 – 3
  • Clinical Decision Thresholds for FNASS

Score < 8: Mild withdrawal symptoms. Continue non-pharmacological care (rooming-in, swaddling, quiet environment).

Score ≥ 8 on 2 consecutive scoring periods OR Score ≥ 12 on a single scoring period: Threshold for initiating pharmacological therapy (typically oral morphine or methadone) alongside non-pharmacological measures.

The Eat, Sleep, Console (ESC) Care Model

In recent years, pediatric and addiction nursing has undergone a major paradigm shift from symptom-counting tools like FNASS to the Eat, Sleep, Console (ESC) care model. Developed by Grossman et al., ESC centers on functional baby-centered capabilities rather than subtle neurodevelopmental signs.

Core Functional Assessment Criteria under ESC

Can the infant EAT adequately? (Feeds appropriate for gestational age: e.g., ≥15–30 mL per feed or effective breastfeeding for ≥10–15 minutes per side without distress).

Can the infant SLEEP soundly? (Sleeps undisturbed for at least 1 hour following a feed).

Can the infant be CONSOLED within 10 minutes? (If crying, can the infant be comforted to a calm state within 10 minutes by a caregiver using non-pharmacological measures?). Eat, Sleep, Console (ESC) Clinical Decision Flow:

Assessed Post-Feed:

  • [EAT: Feed OK?] + [SLEEP: Sleep >=1h?] + [CONSOLE: Consoled <10m?]
  • | |
  • ALL YES ANY NO
  • v v
  • Maintain Non-Pharm Care Maximize Non-Pharm Care
  • (Rooming-In, Skin-to-Skin, (Team Huddle, 24/7 Rooming-In)

Low Stimulation) If persistent functional deficit:

  • Consider Pharmacotherapy
  • Impact of ESC on Nursing Care & Clinical Outcomes

ESC prioritizes parental rooming-in , skin-to-skin contact, quiet dark rooms, and frequent low-volume feedings as the primary treatment. Pharmacotherapy is reserved exclusively for infants with persistent functional deficits despite optimized non-pharmacological care. Large clinical trials demonstrate that ESC dramatically reduces pharmacological treatment rates (from ~50% to <15%) and cuts NICU length of stay from 20+ days to under 6 days.

Perinatal & Pregnant Population Assessment

Screening pregnant individuals for substance use requires a trauma-informed, non-stigmatizing framework. Fear of legal repercussions, child protective services (CPS) involvement, and societal stigma represent severe barriers to disclosure.

Key Nursing Standards for Perinatal Assessment

Universal Screening: Universal verbal screening using validated tools (e.g., 4Ps Plus , SURP-P , NIDA Quick Screen ) should occur at the initial prenatal visit.

Informed Consent for Toxicology: Urine drug screening (UDS) MUST NOT be conducted without explicit informed consent, complying with medical ethics and patient autonomy.

Opioid Maintenance Priority: Pregnant patients with Opioid Use Disorder must be transitioned immediately to agonist maintenance therapy ( Methadone or Buprenorphine ). Acute detoxification is contraindicated during pregnancy due to high rates of relapse and severe fetal stress/stillbirth caused by withdrawal-induced uterine hypertonicity.

Geriatric Substance Use Disorder Assessment

Substance use among older adults (aged 65+) is frequently underdiagnosed due to ageist assumptions and symptom overlap with chronic medical illness or neurocognitive decline.

Age-Related Pharmacokinetic & Assessment Nuances

Altered Pharmacokinetics: Decreased hepatic cytochrome P450 clearance, reduced glomerular filtration rate (GFR), decreased total body water, and increased body fat ratio lead to higher peak serum concentrations and prolonged drug half-lives.

Diagnostic Masking: Alcohol or sedative misuse in older adults often manifests as recurrent falls, cognitive slowing, memory loss, sleep disturbances, or unexplainable bruises—frequently misattributed to dementia or normal aging.

Screening Instrument: The MAST-G (Michigan Alcoholism Screening Test – Geriatric Version) or AUDIT-C (with a reduced positive cut-off score of ≥3) are the validated screening standards for older adults.

Adolescent & Transition-Age Youth Assessment

Adolescent substance use evaluation requires recognizing unique developmental dynamics. The adolescent brain features an accelerated limbic reward system coupled with an immature prefrontal cortex, driving heightened risk-taking behavior.

Essential Nursing Considerations for Adolescent Evaluation

Confidentiality Boundaries: Nurses must explain state-specific minor consent laws and confidentiality limits (e.g., mandatory reporting for active suicidal intent, physical abuse, or severe self-harm).

Screening Standard: CRAFFT screening tool should be universally applied.

Ecological Context: Assess family dynamics, peer influence, school performance, and history of adverse childhood experiences (ACEs).